4114.TWO · SYNMOSA
Taiwan · RS rating 63 · As of 2026-10-08
| Price | 30.15 TWD |
|---|---|
| 1-day change | +3.2% |
| RS rating (overall / 1M / 3M / 12M) | 63 / 60 / 62 / 45 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 34 / 22 / 54 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | +15.8% |
| Sales growth Q/Q | +18.1% |
| Distance from 52-week high | +6.0% |
| Market cap (USD) | $468.4M |